Atlas Trials

Study to Evaluate the Pharmacokinetics of Telotristat Ethyl in Subjects With Severe Hepatic Impairment

Clinical trial NCT03423446 · COMPLETED

Trial details

NCT number
NCT03423446
Sponsor
Lexicon Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2017-11-28
Primary completion
2018-06-15
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.